BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9145927)

  • 1. 3-Morpholino-sydnonimine-induced suppression of human neutrophil degranulation is not mediated by cyclic GMP, nitric oxide or peroxynitrite: inhibition of the increase in intracellular free calcium concentration by N-morpholino-iminoacetonitrile, a metabolite of 3-morpholino-sydnonimine.
    Kankaanranta H; Knowles RG; Vuorinen P; Kosonen O; Holm P; Moilanen E
    Mol Pharmacol; 1997 May; 51(5):882-8. PubMed ID: 9145927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils.
    Wanikiat P; Woodward DF; Armstrong RA
    Br J Pharmacol; 1997 Nov; 122(6):1135-45. PubMed ID: 9401778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential inhibition and potentiation by cell-permeant analogues of cyclic AMP and cyclic GMP and NO-containing compounds of exocytosis in human neutrophils.
    Wenzel-Seifert K; Ervens J; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):396-402. PubMed ID: 1722562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molsidomine inhibits the chemoattractant-induced respiratory burst in human neutrophils via a no-independent mechanism.
    Ervens J; Seifert R
    Biochem Pharmacol; 1992 Aug; 44(4):637-44. PubMed ID: 1324680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of human neutrophil apoptosis by nitric oxide donors: evidence for a caspase-dependent, cyclic-GMP-independent, mechanism.
    Ward C; Wong TH; Murray J; Rahman I; Haslett C; Chilvers ER; Rossi AG
    Biochem Pharmacol; 2000 Feb; 59(3):305-14. PubMed ID: 10609560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes.
    Schröder H; Ney P; Woditsch I; Schrör K
    Eur J Pharmacol; 1990 Jul; 182(2):211-8. PubMed ID: 1697805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxynitrite augments fMLP-stimulated chemiluminescence by neutrophils in human whole blood.
    Bednar MM; Balazy M; Murphy M; Booth C; Fuller SP; Barton A; Bingham J; Golding L; Gross CE
    J Leukoc Biol; 1996 Nov; 60(5):619-24. PubMed ID: 8929553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions.
    Moilanen E; Vuorinen P; Kankaanranta H; Metsä-Ketelä T; Vapaatalo H
    Br J Pharmacol; 1993 Jul; 109(3):852-8. PubMed ID: 8395300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y; Karmazyn M
    Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation.
    Méry PF; Pavoine C; Belhassen L; Pecker F; Fischmeister R
    J Biol Chem; 1993 Dec; 268(35):26286-95. PubMed ID: 7902837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxynitrite is a positive inotropic agent in atrial and ventricular fibres of the frog heart.
    Chesnais JM; Fischmeister R; Mery PF
    J Physiol; 1999 Dec; 521 Pt 2(Pt 2):375-88. PubMed ID: 10581309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP and cyclic GMP independent stimulation of ventricular calcium current by peroxynitrite donors in guinea pig myocytes.
    Malan D; Levi RC; Alloatti G; Marcantoni A; Bedendi I; Gallo MP
    J Cell Physiol; 2003 Nov; 197(2):284-96. PubMed ID: 14502568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cellular mechanism for nitric oxide-mediated cholinergic control of mammalian heart rate.
    Han X; Shimoni Y; Giles WR
    J Gen Physiol; 1995 Jul; 106(1):45-65. PubMed ID: 7494138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human neutrophil function by tolfenamic acid involves inhibition of Ca2+ influx.
    Kankaanranta H; Wuorela H; Siltaloppi E; Vuorinen P; Vapaatalo H; Moilanen E
    Eur J Pharmacol; 1995 Sep; 291(1):17-25. PubMed ID: 8549643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase.
    Wahler GM; Dollinger SJ
    Am J Physiol; 1995 Jan; 268(1 Pt 1):C45-54. PubMed ID: 7530909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that different mechanisms underlie smooth muscle relaxation to nitric oxide and nitric oxide donors in the rabbit isolated carotid artery.
    Plane F; Wiley KE; Jeremy JY; Cohen RA; Garland CJ
    Br J Pharmacol; 1998 Apr; 123(7):1351-8. PubMed ID: 9579730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide regulates the calcium current in isolated human atrial myocytes.
    Kirstein M; Rivet-Bastide M; Hatem S; Bénardeau A; Mercadier JJ; Fischmeister R
    J Clin Invest; 1995 Feb; 95(2):794-802. PubMed ID: 7860763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nitric oxide donor SIN-1 protects endothelial cells from tumor necrosis factor-alpha-mediated cytotoxicity: possible role for cyclic GMP and heme oxygenase.
    Polte T; Oberle S; Schröder H
    J Mol Cell Cardiol; 1997 Dec; 29(12):3305-10. PubMed ID: 9441836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH; Cheng JT; Teng CM
    Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Trolox C and SIN-1 on arachidonic acid metabolism and on cyclic GMP formation in leukocytes.
    Riutta A; Alanko J; Mucha I; Vapaatalo H
    Eur J Pharmacol; 1994 Sep; 262(3):217-22. PubMed ID: 7813586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.